Sartorius Stedim Biotech reported a slight revenue decrease and significant drops in net profit and EBITDA for the first half of 2024, leading to a cautious...
In 2022, spending on biotechnology Research and Development (R&D) increased by 13% to reach 2.56 billion euros. Company expenditure grew by 17.8%, accounting for 47.7% of...